8-K: Visium Technologies Signs Non-Binding Deal for Indonesian Rights

Visium Technologies has executed a non-binding term sheet to assign specified contract-use, offtake, and deployment rights into a new Indonesian entity, with a Delaware subsidiary holding a 99% stake.

Summary

• Visium Technologies announced the execution of a non-binding term sheet for the assignment of specified contract-use, offtake, and deployment rights.
• These rights will be assigned into a newly formed Indonesian limited-liability PMA company, PT Visium Compute Indonesia (PTVCI).
• A wholly owned Delaware subsidiary of Visium will hold a 99% equity interest in PTVCI, with a local nominee holding the remaining 1%.
• The transaction is structured as an assignment of rights, not an acquisition of an existing operating company, and will not make Visium a semiconductor manufacturer or OEM.
• The term sheet is non-binding except for provisions on exclusivity, confidentiality, expenses, and governing law.
• Economic terms, including the consideration (expected to be Series F Preferred Stock), are subject to Board authorization.
• Closing is contingent on numerous conditions, including final device specifications, consents, regulatory approvals, and corporate approvals under Florida law.
• There is no assurance that the conditions will be met, a definitive agreement will be reached, or the transaction will close.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a low score due to the highly conditional nature of the announced term sheet and the significant outstanding conditions and corporate approvals required, indicating substantial uncertainty.

Positives

• The proposed transaction aims to assign specific contract-use, offtake, and deployment rights into a new entity.
• Visium's subsidiary will hold a controlling 99% equity interest in the new Indonesian company.
• The structure avoids the acquisition of an existing operating company and associated historical liabilities.
• The term sheet includes binding provisions for exclusivity and confidentiality.

Negatives

• The term sheet is non-binding regarding key economic terms, which require further Board authorization.
• Numerous conditions must be satisfied for the transaction to close, including regulatory and third-party consents.
• There is significant uncertainty regarding whether a definitive agreement will be reached or if the transaction will close.
• The company has previously expressed substantial doubt about its ability to continue as a going concern.

Risks

• Failure to satisfy numerous closing conditions, including obtaining required consents and regulatory approvals.
• Inability to secure sufficient authorized capital following a recent reverse split and share reduction.
• Potential for the term sheet to expire if a definitive agreement is not entered into by the specified date.
• The company's ability to continue as a going concern remains a significant risk.
• Directors' conflict of interest transactions require review and approval under Florida law, which has not been completed.
• The need for additional qualified directors or shareholder action to approve the transaction due to board composition.

Future Outlook

The company has previously expressed substantial doubt about its ability to continue as a going concern. The future outlook for this specific transaction is highly uncertain, dependent on numerous conditions precedent and corporate approvals.

Management Comments

• "Markets do not pay for adjectives. They pay for rights that survive a closing. We are not announcing a factory, a partner, or a watt. We are putting a defined bundle of rights into a clean vehicle, leaving every inherited liability where it belongs, and refusing to call the work finished until the last condition exists in fact."
• "Investors should rely solely on the Companys filings with the Securities and Exchange Commission."

Industry Context

StockSavvy.ai notes that this announcement reflects a common strategy for technology companies seeking to monetize specific intellectual property or contract rights without undertaking full-scale manufacturing or operational expansion, particularly in emerging markets like Indonesia.

Corporate Governance

Related Party Transactions

• Certain persons who beneficially own voting securities, including an entity associated with Dr. Niclas Adler, and the Chairman and CEO, Paul R. Taylor, have relationships with parties expected to participate in the proposed transaction.
• A Mutual Collaboration Agreement dated March 31, 2026, exists between Mr. Taylor and PT Smart Green Technology Pte Ltd.

Stakeholder Impact

• Shareholders: The transaction involves the issuance of preferred stock, which could dilute common stock value and alter voting control depending on its terms and conversion rights. The uncertainty surrounding the deal's closure also impacts investor confidence.
• Creditors: The company's ongoing going concern issues may affect its ability to meet obligations.
• Management/Employees: The transaction's success or failure could impact future strategic direction and operational stability.

Next Steps

• Authorization of economic terms, including Series F Preferred Stock, by the Company's Board of Directors.
• Satisfaction of numerous closing conditions, including obtaining required consents and regulatory approvals.
• Execution of a definitive agreement, if conditions are met.
• Potential closing of the proposed transaction.
• Filing of a subsequent Current Report on Form 8-K if a material definitive agreement is entered into.
• Filing of a Current Report under Item 3.02 if Series F Preferred Stock is issued.

Key Dates

Recommendation

The filing outlines a non-binding term sheet with significant conditions and corporate approvals still pending. While it represents a potential step towards monetizing assets, the high degree of uncertainty and the company's ongoing going concern issues warrant a cautious 'hold' stance until definitive agreements are reached and conditions are met.

Keywords

assignment of rights, Indonesian entity, term sheet, contract-use, offtake rights, deployment rights, preferred stock, regulatory approvals